Quest Diagnostics Inc (DGX) Stock Price Today
Aura AI Summary
Key Stats
- $25.96BMarket Cap
- -Volume
- HealthSector
- $235.9452W High
- $167.4152W Low
- -Typical Hold Time
- $31.72BEnterprise Value
- 1.46%Div Yield
- -Trading Activity
Track Quest Diagnostics Inc (DGX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Quest Diagnostics Inc has traded between a low of $167.41 and a high of $235.94, highlighting its annual price range. Buy and sell Quest Diagnostics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Most Recent News
Inno Holdings stock to resume Nasdaq trading July 31, delayed to noon ET.
Inno Holdings Inc., a Texas-based electronic products trading company, announced that its common stock will resume trading on The Nasdaq Capital Market on July 31, 2026, around noon Eastern Time. This follows a trading halt imposed by Nasdaq under Co...

FDA advisory panel finds Replimune's RP1 effective for advanced melanoma, supporting FDA review.
The FDA's advisory committee voted 10 to 3 that the efficacy results from Replimune's IGNYTE study on RP1 combined with nivolumab for advanced melanoma are evaluable and clinically meaningful. This positive outcome supports the ongoing FDA review of ...

Alphabet downgraded to Hold amid AI delays and rising competition from Microsoft
Investment firm UBS downgraded Alphabet Inc. stock to "Hold" due to delays in its AI model Gemini 3.5 Pro and increased competition from Microsoft, which reported strong AI and cloud growth. Alphabet is also under investigation for potential securiti...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.